We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
LendingTree
TREE
$451M
| $8.39M | ﹤0.01% |
28,965
+268
| +0.9% | +$64.7K |
|
1602
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $8.39M | ﹤0.01% |
329,102
+62,915
| +24% | +$1.31M |
|
|
GTY
1603
Getty Realty Corp
GTY
$2.07B
| $8.38M | ﹤0.01% |
282,536
-44,132
| -14% | -$1.17M |
|
1604
Gray Television
GTN
$552M
| $8.38M | ﹤0.01% |
600,854
+17,116
| +3% | +$219K |
|
|
HI
1605
DELISTED
Hillenbrand
HI
| $8.38M | ﹤0.01% |
309,535
+22,168
| +8% | +$503K |
|
|
FBM
1606
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $8.37M | ﹤0.01% |
535,997
-190,913
| -26% | -$2.41M |
|
|
PFC
1607
DELISTED
Premier Financial Corp. Common Stock
PFC
| $8.37M | ﹤0.01% |
473,510
+101,771
| +27% | +$1.65M |
|
1608
TG Therapeutics
TGTX
$7.62B
| $8.36M | ﹤0.01% |
429,214
-203,499
| -32% | -$3.28M |
|
|
PACW
1609
DELISTED
PacWest Bancorp
PACW
| $8.35M | ﹤0.01% |
423,662
-277,612
| -40% | -$5.14M |
|
1610
Canadian Pacific Kansas City
CP
$80.5B
| $8.34M | ﹤0.01% |
+163,355
| New | +$7.75M |
|
1611
NETSCOUT
NTCT
$2.79B
| $8.33M | ﹤0.01% |
325,945
+42,969
| +15% | +$1.11M |
|
|
PS
1612
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $8.31M | ﹤0.01% |
460,483
-10,851
| -2% | -$184K |
|
1613
Viasat
VSAT
$11.1B
| $8.3M | ﹤0.01% |
216,365
+21,087
| +11% | +$857K |
|
1614
Tactile Systems Technology
TCMD
$665M
| $8.3M | ﹤0.01% |
200,348
-56,366
| -22% | -$2.64M |
|
|
SASR
1615
DELISTED
Sandy Spring Bancorp Inc
SASR
| $8.28M | ﹤0.01% |
334,137
+27,491
| +9% | +$653K |
|
1616
NBT Bancorp
NBTB
$2.74B
| $8.27M | ﹤0.01% |
268,832
-19,615
| -7% | -$611K |
|
1617
Onto Innovation
ONTO
$15.3B
| $8.26M | ﹤0.01% |
242,784
+5,456
| +2% | +$177K |
|
1618
Purple Innovation
PRPL
$41.7M
| $8.26M | ﹤0.01% |
18,359
+6,030
| +49% | +$1.9M |
|
1619
Omeros
OMER
$959M
| $8.25M | ﹤0.01% |
560,599
+338,959
| +153% | +$5.06M |
|
1620
Enviri
NVRI
$620M
| $8.25M | ﹤0.01% |
610,335
-499,636
| -45% | -$5.02M |
|
1621
Ligand Pharmaceuticals
LGND
$6.36B
| $8.23M | ﹤0.01% |
118,027
-71,760
| -38% | -$4.55M |
|
1622
Carlyle Group
CG
$17.2B
| $8.23M | ﹤0.01% |
+294,816
| New | +$7.57M |
|
1623
BioXcel Therapeutics
BTAI
$27.8M
| $8.22M | ﹤0.01% |
9,688
+54
| +0.6% | +$35.2K |
|
1624
APi Group
APG
$18B
| $8.2M | ﹤0.01% |
+1,011,978
| New | +$7.66M |
|
|
USCR
1625
DELISTED
U S Concrete, Inc.
USCR
| $8.18M | ﹤0.01% |
329,692
+36,573
| +12% | +$733K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.